R. P. Baughman (Cincinnati, United States of America), D. Valeyre (Paris, France)
Morphometric study of blood and lymphatic vasculature in fibrotic lung diseases
P. Sestini, F. Sozio, A. Rossi, A. G. Nicholson, A. U. Wells, E. Renzoni, E. Weber (Siena, Italy; London, United Kingdom)
|  |
Manifestation peculiarities of organizing pneumonia
E. Danila, E. Zurasuskas, R. Zablockis, R. Nargela (Vilnius, Lithuania)
|  |
Does surgical lung biopsy change the diagnosis and treatment in interstitial lung diseases?
H. Kiral, T. Ceylan, M. Kupeli, I. Ocakcioglu, E. Okur, A. Turna, F. Aksoy, I. Yalcinkaya (Istanbul, Turkey)
| |
Clinical analysis of chronic hypersensitivity pneunonitis – Comparison with idiopathic pulmonary fibrosis
M. Sawahata, T. Ogura, E. Hagiwara, T. Kato, S. Komatsu, T. Baba, J. Shiihara, T. Endo, T. Shinohara, T. Takemura, H. Takahashi (Yokohama, Tokyo, Japan)
| |
Difficulties of lymphocytic interstitial pneumonia diagnostic
I. Dvorakovskaya, R. Grozov, L. Novikova, O. Baranova (St. Petersburg, Russian Federation)
| |
Prospective multicentric study to evaluate the role of video-assisted thoracoscopic lung biopsy in the diagnosis of interstitial lung disease: Evolving concepts
J. Fibla, L. Molins, A. Blanco, I. Royo, P. Martinez, N. Martinez, A. Arnau, S. Garcia, A. Gomez, E. Canalis, M. Estors, M. Moldes, E. Fernandez, A. Carvajal, P. Leon, P. Rodriguez, J. Freixinet (Barcelona, Sevilla, Zaragoza, Valencia, Madrid, Tarragona, Santiago de Compostela, Badalona, Palma de Mallorca, Albacete, Badajoz, Las Palmas de Gran Canaria, Spain)
| |
Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia
A. Kaga, Y. Yusui, F. Sakai, R. Sadakata, K. Kobayashi, M. Nagata, K. Hagiwara, M. Kanazawa (Saitama, Japan)
| |
Thoracic thin-section CT manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease
K. Honda, F. Okada, Y. Ando, H. Kiyosue, S. Matsumoto, H. Mori (Oita, Japan)
| |
Physical activities of daily life in ILD patients compared to COPD patients
S. Perez-Bogerd, D. Langer, W. Wuyts, V. Barbier, C. Burtin, M. Decramer, W. Janssens, T. Troosters (Leuven, Belgium)
| |
Prognostic value of SVC change in fibrotic idiopathic interstitial pneumonia
F. Novelli, S. Cini, F. Aquilini, L. Melosini, L. Malagrinò, L. Tavanti, P. Paggiaro (Pisa, Italy)
| |
Reduced exercise capacity and impaired pulmonary function in patients with scleroderma
M. Messina, N. Scichilone, S. Battaglia, M. Bellia, M. Midiri, A. Paternò, A. Giardina, G. Triolo, V. Bellia (Italy)
| |
Assessment of health related quality of life in interstitial lung diseases (ILD) using the St George‘s Respiratory Questionnaire (SGRQ) and Short Form-36 (SF 36)
A. S. Patel, K. Brignall, K. K. Lee, I. Higginson, A. Wells, S. S. Birring (London, United Kingdom)
| |
Scleroderma lung disease: Risk factors and treatment options
M. Rebelo, J. Lima, J. Vieira, J. Nascimento Costa (Portugal)
| |
Clinical characteristics of Czech patients with sarcoidosis: A case review of 124 patients
J. Anton, M. Vasakova (Prague, Czech Republic)
| |
Changes in pulmonary 18F-FDG SUVmax reflect treatment response in patients with diffuse parenchymal lung disease; a PET/CT proof of concept study
T. Win, N. Screaton, I. Kayani, M. Shastry, R. Endozo, R. Shortman, B. Hutton, P. Ell, A. Groves (Stevenage, Cambridge, United Kingdom)
| |
Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF
G. Margaritopoulos, E. Vassalou, K. Karagiannis, R. Lymbouridou, I. Lasithiotaki, I. Lambiri, N. Siafakas, K. Antoniou (Heraklion, Greece)
| |
Pulmonary involvement in patients diagnosed with inflammatory joint and connective disease in a multidisciplinary outpatient surgery
L. Gomez Carrera, E. Martinez Cerón, C. Llontop Guzmán, G. Bomilla Hernán, C. Plascencia, R. Alvarez Sala, E. Martin Mola (Madrid, Spain)
| |
Clinical characteristics of amyloidosis with involvement of the respiratory system: An analysis of 13 cases
H. Chu, J. Liu, L. Liu, L. Zhao, T. Gui, X. Yi (Shanghai, China)
| |
Hormone replacement therapy associated with improved oxygenation in women with IPF
M. Han, K. Flaherty, G. Toews, R. Edwards, K. Anstrom, F. Martinez (Ann Arbor, Raleigh, United States Of America)
| |
Efficacy of two liquid oxygen dconserving devices in deambulation in patients with interstitial lung disease
V. Pajares, F. Morante, A. Ramon, S. Marti, T. Codinachs, J. Lara, R. Güell (Barcelona, Spain)
| |